Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Brain volume in depression.

Maany I.

J Clin Psychiatry. 2013 Jun;74(6):631. doi: 10.4088/JCP.12lr08004. No abstract available.

PMID:
23842017
2.

Ms Phillips and Dr Blier reply.

Phillips JL, Blier P.

J Clin Psychiatry. 2013 Jun;74(6):631-2. doi: 10.4088/JCP.12lr08004a. No abstract available.

PMID:
23842018
3.

Brain-volume increase with sustained remission in patients with treatment-resistant unipolar depression.

Phillips JL, Batten LA, Aldosary F, Tremblay P, Blier P.

J Clin Psychiatry. 2012 May;73(5):625-31. doi: 10.4088/JCP.11m06865. Epub 2012 Feb 21.

PMID:
22394416
4.

Duloxetine related effects of brain structure on a patient of major depressive disorder with panic disorder.

Lai CH.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):240-1. doi: 10.1016/j.pnpbp.2009.10.004. Epub 2009 Oct 13. No abstract available.

PMID:
19833160
5.

Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies.

Delaveau P, Jabourian M, Lemogne C, Guionnet S, Bergouignan L, Fossati P.

J Affect Disord. 2011 Apr;130(1-2):66-74. doi: 10.1016/j.jad.2010.09.032. Epub 2010 Oct 27.

PMID:
21030092
6.

The effects of antidepressants on human brain as detected by imaging studies. Focus on major depression.

Bellani M, Dusi N, Yeh PH, Soares JC, Brambilla P.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1544-52. doi: 10.1016/j.pnpbp.2010.11.040. Epub 2010 Dec 4. Review.

PMID:
21138750
7.

Molecular neurobiology of major depressive disorder.

Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:275-6. doi: 10.1016/j.pnpbp.2015.07.004. Epub 2015 Jul 11. No abstract available.

PMID:
26169576
8.

Drugs for depression and bipolar disorder.

[No authors listed]

Treat Guidel Med Lett. 2010 May;8(93):35-42. Review. No abstract available.

PMID:
20414177
9.

Abnormal neural activity of brain regions in treatment-resistant and treatment-sensitive major depressive disorder: a resting-state fMRI study.

Guo WB, Liu F, Chen JD, Gao K, Xue ZM, Xu XJ, Wu RR, Tan CL, Sun XL, Liu ZN, Chen HF, Zhao JP.

J Psychiatr Res. 2012 Oct;46(10):1366-73. doi: 10.1016/j.jpsychires.2012.07.003. Epub 2012 Jul 25.

PMID:
22835912
10.

Glutamate hypothesis of depression and its consequences for antidepressant treatments.

Musazzi L, Treccani G, Popoli M.

Expert Rev Neurother. 2012 Oct;12(10):1169-72. doi: 10.1586/ern.12.96. No abstract available.

12.

Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment.

Vythilingam M, Vermetten E, Anderson GM, Luckenbaugh D, Anderson ER, Snow J, Staib LH, Charney DS, Bremner JD.

Biol Psychiatry. 2004 Jul 15;56(2):101-12.

PMID:
15231442
13.

Brain, networks, depression, and more.

Leistedt SJ, Linkowski P.

Eur Neuropsychopharmacol. 2013 Jan;23(1):55-62. doi: 10.1016/j.euroneuro.2012.10.011. Epub 2012 Nov 13. Review.

PMID:
23154052
14.

Major depressive disorder.

Schechter LE.

Curr Pharm Des. 2005;11(2):143-4. No abstract available.

PMID:
15638754
15.

Open questions in current models of antidepressant action.

Tanti A, Belzung C.

Br J Pharmacol. 2010 Mar;159(6):1187-200. doi: 10.1111/j.1476-5381.2009.00585.x. Epub 2010 Feb 2. Review.

16.
17.

Proceedings: Influence of azaphen, a new antidepressive drug, on the human EEG.

Misurec J, N√°hunek K, Kamenick√° V, Chmelar M.

Act Nerv Super (Praha). 1974;16(4):245-6. No abstract available.

PMID:
4450998
18.

Catecholaminergic strategies for the treatment of major depression.

Tremblay P, Blier P.

Curr Drug Targets. 2006 Feb;7(2):149-58. Review.

PMID:
16475956
19.

Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies.

Rigucci S, Serafini G, Pompili M, Kotzalidis GD, Tatarelli R.

World J Biol Psychiatry. 2010 Mar;11(2 Pt 2):165-80. doi: 10.1080/15622970903131571. Review.

PMID:
19670087
20.

Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent.

Stahl SM.

CNS Spectr. 2007 Oct;12(10):739-44. Review. No abstract available.

PMID:
17934378

Supplemental Content

Support Center